PA
RVMDW icon

Perceptive Advisors’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Perceptive Advisors’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$448K Hold
250,000
– – 0.01% 91
2025
Q4 		$235K Hold
250,000
– – ﹤0.01% 114
2025
Q3 		$75K Hold
250,000
– – ﹤0.01% 91
2025
Q2 		$65.7K Hold
250,000
– – ﹤0.01% 84
2025
Q1 		$9.5K Hold
250,000
– – ﹤0.01% 86
2024
Q4 		$45K Hold
250,000
– – ﹤0.01% 98
2024
Q3 		$35K Hold
250,000
– – ﹤0.01% 106
2024
Q2 		$25.5K Hold
250,000
– – ﹤0.01% 108
2024
Q1 		$45.6K Hold
250,000
– – ﹤0.01% 110
2023
Q4 		$82.5K Buy
+250,000
New +$112K ﹤0.01% 98

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Perceptive Advisors's RVMDW Position: Q1 2026 in Review

Perceptive Advisors held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q1 2026 at 250,000 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #91.

Perceptive Advisors first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • Perceptive Advisors held 250,000 shares of Revolution Medicines Inc Warrant worth $448K as of Q1 2026.
  • Perceptive Advisors left its Revolution Medicines Inc Warrant share count unchanged in Q1 2026.
  • Revolution Medicines Inc Warrant made up 0.01% of Perceptive Advisors's portfolio in Q1 2026, its #91 holding.
  • Perceptive Advisors first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.